Forus
Category: AI in Healthcare
An AI-driven operating system for medical prescriptions that automates the end-to-end workflow between doctors, insurance payers, and pharmacies. Forus was founded in 2023. The company is led by Sahir Jaggi. Based in New York, USA. Team size: 11-50. Total funding raised: Undisclosed. Latest round: Series B. Key investors include Thrive Capital, Pear VC, BoxGroup, Mario Schlosser.
AMW Analysis
Tandem operates an AI-driven operating system for medical prescriptions that automates the end-to-end workflow between doctors, insurance payers, and pharmacies. The company reduces medication wait times by automating prior authorization and clinical documentation, aiming to lower administrative burnout and improve patient adherence. Founded in 2023 and based in New York, Tandem was acquired by Vensure in July 2024 for an undisclosed price.
Recent news flow shows a significant shift in direction. In January 2026, Tandem Technology (the same entity) reached a $1 billion valuation after securing $100 million in funding led by Accel. The round targets automating prior authorizations and pharmacy routing through a zero-cost model for providers. This funding event marks a move toward embedded AI infrastructure that eliminates systemic administrative waste, following the earlier acquisition by Vensure. The company’s valuation and capital raise suggest scaled operations, though the relationship between the acquisition and subsequent independent funding remains unclear from the available facts.
AMW analysis, generated from 3 tracked news signals.
- Founded
- 2023
- Headquarters
- New York, USA
- Team size
- 11-50
- Total funding
- Undisclosed
Value proposition
Reduces the medication wait time from weeks to hours by automating the prior authorization process and clinical documentation, significantly lowering administrative burnout and improving patient adherence.
Products and solutions
AI Prior Authorization Engine, Automated Pharmacy Coordination Platform, Clinical Documentation & Scribe Tools, Payer Rule Intelligence Dashboard, Patient Medication Access Tracker
Unique value
Unlike generic AI scribes, Tandem focuses specifically on the 'last mile' of care—ensuring the prescription is actually filled by navigating the complex intersection of clinical intent and insurance restrictions.
Target customer
Healthcare providers, specialty medical clinics, health systems, and clinical administrative staff.
Industries served
Healthcare Technology, Health Insurance (Payers), Pharmaceuticals, SaaS (Healthtech)
Technology advantage
Leverages proprietary Large Language Models (LLMs) trained on complex payer-provider data schemas. The leadership team’s deep background at Oscar Health provides a unique 'insider' understanding of insurance adjudication logic that is difficult for competitors to replicate.
How they differentiate
Tandem differentiates by focusing on the 'last mile' of the prescription process. While competitors often focus on general clinical documentation or simple electronic prior authorizations, Tandem uses proprietary LLMs to navigate the complex intersection of clinical intent and specific insurance adjudication logic to ensure medications are actually dispensed.
Main competitors
CoverMyMeds, Cohere Health, Ambience Healthcare, PriorAuthNow
Key partnerships
Thrive Capital, Pear VC, BoxGroup, Strategic alignment with Oscar Health ecosystem (via founder Mario Schlosser)
Notable customers
Oscar Health (Strategic Partner), Specialty Medical Groups, Large-scale Health Systems
Major milestones
Founded in 2023 by former Oscar Health product lead Sahir Jaggi, Successfully automated the 'last mile' of prescription fulfillment, reducing wait times from weeks to hours, Achieved a $1 billion valuation, Rebranded from Tandem to Forus and raised $160M Series B (May 2026)
Growth metrics
Reached Unicorn status with a $1 billion valuation within three years of founding; expanded from initial pilot clinics to enterprise-scale health system deployments.
Market positioning
Premium AI-infrastructure provider for specialty clinics and large health systems, positioning itself as the 'intelligent operating system' for prescription workflows.
Geographic focus
United States (specifically targeting the complex US payer-provider insurance landscape).
Patents and IP
No specific public patent filings disclosed; relies on proprietary algorithms and trade-secret data processing workflows.
About Sahir Jaggi
Sahir Jaggi is a seasoned healthtech leader with over 6 years at Oscar Health, where he rose to Director of Product Strategy. He played a pivotal role in building Oscar's care delivery and patient experience infrastructure. His background combines technical expertise (Biomedical Engineering/CS from Columbia) with venture experience as a Partner at Rough Draft Ventures.
Latest news about Forus
- Amsterdam-based Delphyr has raised €1.75 million to scale AI agents that reduce administrative workloads for healthcare professionals, with backing from Hugging Face founders and DEGIRO. Founded by an
- Healthcare AI startup Tandem Technology is reaching a 1 billion dollar valuation with a 100 million dollar funding round led by Accel. By automating administrative bottlenecks like prior authorization
- Tandem Technology Inc. has reached a 1 billion dollar valuation after securing 100 million dollars in funding led by Accel. The startup utilizes AI to automate prescription paperwork, specifically tar
More AI in Healthcare companies
Official website: https://forus.com/
